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Abstract
During the past decade extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae have become a matter of
great concern in human and veterinary medicine. In this cross-sectional study fecal swabs of a geographically representative
number of Swiss cattle at slaughterhouse level were sampled i) to determine the occurrence of ESBL producing
Enterobacteriaceae in the Swiss slaughter cattle population younger than 2 years, and ii) to assess risk factors for shedding
ESBL producing Enterobacteriaceae. In total, 48 (8.4%; 95% C.I. 6.3–11.1%) independent ESBL producing Enterobacteriaceae
were detected among the 571 tested animals. Species identification revealed 46 E. coli strains, one Enterobacter cloacae and
one Citrobacter youngae. In view of beta-lactam antibiotics, all 48 isolates were resistant to ampicillin, cephalothin and
cefpodoxime. Forty-five (93.8%) isolates were resistant cefuroxime; one (2.1%) isolate to cefoxitin, 28 (58.3%) isolates to
cefotaxime, 2 (4.2%) isolates to ceftazidime, and 2 (4.2%) isolates to cefepime. Risk factors for shedding ESBL producing
Enterobacteriaceae were (i) age (OR 0.19 and 0.12 in age category 181 d to 1y and 1y to 2 y compared to#180 d), (ii) primary
production type, meaning dairy compared to beef on farm of origin (OR 5.95), and (iii) more than 1 compared to less than 1
animal movement per d per 100 animals on farm of origin (OR 2.37).
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Introduction
Antimicrobial resistance in bacteria has emerged as a problem
in both human and veterinary medicine. One of the currently
most important resistance mechanisms in Enterbacteriaceae, which
reduces the efficacy even of modern expanded-spectrum cepha-
losporins (except cephamycins and carbapenems) and monobac-
tams is based on plasmid-mediated production of enzymes that
inactivate these compounds by hydrolyzing their beta-lactam ring.
Such resistance is encoded by an increasing number of different
point-mutational variants, called extended spectrum beta-lacta-
mases (ESBL), of classical broad-spectrum beta-lactamases (BSBL):
most are derivates of TEM and SHV beta-lactamase families,
whereas other groups, such as CTX-M, OXA, PER and VEB
beta-lactamases have been described more recently [1]. The
phenotypical difference between BSBLs and ESBLs is that the
latter efficiently hydrolyze 3rd- and 4th-generation cephalosporins,
in addition to penicillins and 1st and 2nd generation cephalosporins
as the BSBLs are capable of. ESBLs are inhibited by clavulanic
acid, sulbactam and tazobactam [2], a feature that is used (i) as a
criterion for classification of b-lactamases and (ii) for diagnostic
ESBL detection purposes. As a matter of growing concern,
resistance caused by ESBLs is often associated with resistance to
other classes of antibiotics like fluoroquinolones, aminoglycosides
and trimethoprim-sulfamethoxazole [3,4].
Since the first description of ESBL producing Enterobacteriaceae
isolated from hospitalized humans [5], many nosocomial out-
breaks have been reported. However, since a few years, there is an
increase in the detection of ESBL producing strains in the
community [6,7]. More recently, some reports have alerted about
the dissemination of ESBL producing E. coli in healthy cattle in
several countries in Europe and USA [8,9,10] or in cattle derived
food products like meat and raw milk [11,12,13]. Therefore, the
impact of healthy farm animals as a reservoir for an input of ESBL
producing E. coli in the food processing chain has to be assessed.
The aim of the present study was to assess the prevalence of
ESBL producing Enterobacteriaceae in the Swiss cattle population
younger than two years, and to assess risk factors for shedding
ESBL producing Enterobacteriaceae based on a slaughterhouse
monitoring approach that is aiming at achieving a geographically
representative sample. Whilst for monitoring purposes a geo-
graphically representative set is easily achieved for samples taken
on a farm level, where farms to be sampled can be determined in
advance by applying a stratified randomization scheme, this is
typically more difficult for samples taken at the slaughterhouse.
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Materials and Methods
Sampling
Representative samples for the cattle population younger than
2 years were taken at the slaughterhouse level. A minimum
required sample size of 385 randomly selected animals was
calculated with the assumptions of an infinite population size, a
prevalence of 50%, a desired confidence level of 95.0% and an
absolute error of 5% (Win Episcope 2.0 software http://www.
clive.ed.ac.uk/winepiscope). The samples were randomly taken at
the five biggest cattle abattoirs (A: Zurich; B: Hinwil; C: St. Gallen;
D: Oensingen; E: Estavayer-le-Lac), where over 75% of Swiss
cattle of the targeted age group are slaughtered. Because animals
originating from farms located south of the Alps are typically
underrepresented in the slaughter population of these 5 biggest
abattoirs, samples from the biggest abattoir in the canton of Ticino
(F: Bellinzona) and samples from several smaller abattoirs from the
canton of Valais were additionally collected to guarantee a
geographically representative distribution. From all the abattoirs
we obtained the permission to use these animal parts.
Only one sample was taken per animal holding of origin. The
number of samples in the sampling frame collected from each
slaughterhouse was proportional to the number of cattle slaugh-
tered at each establishment per year. Based on these data, a
random sampling plan was conceived.
Faecal swabs were collected from November 2010 to September
2011 from 571 healthy animals younger than 2 years at slaughter.
These animals had no contact to older cattle populations on the
transport to the slaughterhouse, in the slaughterhouse or during
the slaughtering procedure. Therefore, contamination by animals
of older age classes after having left the farm of origin can be
excluded. The samples were taken through opening the large
intestine with sterile scissors after evisceration. Unique animal
identification numbers registered in the Swiss central animal
movement database (AMD) were recorded.
Microbiological analysis
Each swab was incubated for 24 hours at 37uC in 10 ml EE
Broth (BD, Franklin Lakes, USA) for enrichment. One loop of the
enriched faecal samples were inoculated onto Brilliance ESBL
agar (Oxoid, Hampshire, UK) and incubated at 37uC for 24 hours
under aerobic conditions. All grown colonies were selected and
sub-cultured onto Triple Sugar Iron (TSI) agar (BD, Franklin
Lakes, USA) at 37uC for 24 hours. By the oxidase test and the
assessment of lactose fermentation, non-fermenters were discard-
ed, and oxidase-negative colonies were subjected to identification
by API ID 32 E (bioMe´rieux, Marcy l’Etoile, France).
Antimicrobial susceptibility testing and ESBL detection
All isolated strains were subjected to susceptibility testing for 18
antimicrobial agents by the disc diffusion method and evaluated
according to CLSI criteria [14]. Strains exhibiting intermediate
resistance were classified as susceptible. The antibiotics tested
were: ampicillin (AM, 10 mg), amoxicillin/clavulanic acid (AMC,
20/10 mg), cephalothin (CF, 30 mg), cefuroxime (CXM, 30 mg),
cefoxitin (FOX, 30 mg), cefpodoxime (CPD, 10 mg), cefotaxime
(CTX, 30 mg), ceftazidime (CAZ, 30 mg), cefepime (FEP, 30 mg),
ciprofloxacin (CIP, 5 mg), nalidixic acid (NA, 30 mg), gentamicin
(GM, 10 mg), streptomycin (S, 10 mg), trimethoprim-sulfamethox-
azole (SXT, 1.25/23.75 mg), chloramphenicol (C, 30 mg) and
tetracycline (TE, 30 mg). The amoxicillin/clavulanic acid disc was
placed between the cefpodoxime and the ceftazidime discs, and
the synergy effect was documented. The strains, which showed a
synergy effect, were then confirmed as ESBL producers on Muller-
Hinton agar plates using E-Test-ESBL strips containing cefotax-
ime, cefepime or ceftazidime alone and in combination with
clavulanic acid (bioMe´rieux, Marcy l’Etoile, France).
Risk Factor Analysis
Risk factors were calculated based on data obtained from the
Swiss AMD. The individual animal identification number of the
Table 1. Description of risk factors studied in univariate and multivariate logistic regression models.
Risk factor Category Number of animals Proportion of positive samples
Age Class #180 d 248 15.7%
181 d–1 y 148 3.4%
.1 y 175 2.3%
Production Type Meat 244 2.5%
Dairy 327 12.8%
Number of cattle on farm #30 173 6.4%
31–60 211 8.1%
.60 187 10.7%
Animal movements to farm #0.5 428 6.3%
per day .0.5 143 14.7%
Animal movements to farm #1/d/100 animals 461 6.9%
per day per 100 animals .1/d/100 animals 110 14.6%
Number of animals dying 0 235 10.2%
on farm per 100 days #1/100 d 185 4.3%
.1/100 d 151 10.6%
Number of animals dying on 0 235 10.2%
farm per 100 days per 100 #2/100 d 200 4.0%
animals .2/100 d 136 11.8%
doi:10.1371/journal.pone.0071725.t001
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slaughtered and sampled animals served as a unique identifier to
determine the farm of origin, date of birth and to access all
incoming movement data corresponding to the farm of origin and
the length of stay of each individual animal of the sample. Risk
factors derived from AMD data comprised age, main production
type on the farm of origin (dairy vs. beef and fattening), farm size,
number of animal movements and number of animals found death
or euthanized on farm. The full list of studied risk factors and their
categorization is given in Table 1.
Statistical Analysis
Statistical analyses were performed in R version 2.13 for Mac
OS. The significance level was set at p#0.05. ESBL prevalence
and their Yates’ continuity corrected 95% confidence intervals
were calculated applying exact binomial tests. Logistic regression
models were applied for risk factor analyses. First, a univariate
model was calculated for each risk factor given in Table 1. Risk
factors with a p-value ,0.25 were retained for multivariate
analyses. To avoid colinearity, the correlation structure of these
retained risk factors was assessed. Of each pair of correlating risk
factors, only the one showing the more significant association with
the dependent variable was retained for the multivariate model.
Multivariate models were fitted by backward elimination proce-
dures. According to Hosmer and Lemeshow [15] confounders
were eliminated if they did not importantly change the estimates of
the significant predictors. All two ways interactions were tested.
Results
The sampling regimen resulted in a geographically representa-
tive sample population that was uniformly spread over the entire
territory of Switzerland. Farms of origin of cattle shedding ESBL-
producing Enterobacteriaceae are as well uniformly spread over the
densely populated Swiss midlands as well as over the canton of
Ticino in the south east of Switzerland. There were no cattle
shedding ESBL-producing Enterobacteriaceae found originating from
the canton of Valais in the south west of Switzerland.
ESBL-producing Enterobacteriaceae were detected in 48 (8.4%;
95% C.I. 6.3–11.1%) of the 571 tested animals. ESBL prevalence
in different age classes, different production types and different
animal movement activities in the farm of origin are summarized
in Table 2. Results of the final multivariate logistic regression
models applied for risk factor analysis are shown in Tables 3 and 4.
Animals from within the age class #180 days were at a
significantly higher risk of shedding ESBL-producing Enterobacte-
riaceae than animals from age classes 180 days to 1 year or 1 year
to 2 years. Animals originating from farms with primary
production type ’’dairy‘‘ were at a 5.95 times greater risk of
shedding ESBL-producing Enterobacteriaceae than animals originat-
ing from farms with primary production type ’’beef‘‘. Finally,
animals originating from farms with more than one animal
movement per day per 100 animals were at a 2.37 times higher
risk of shedding ESBL-producing Enterobacteriaceae than animals
originating form farms with less than one animal movement per
day100 animals.
In total, 48 isolates from 48 different animals showing the ESBL
phenotype were further characterized. Species identification
revealed 46 E. coli, one Enterobacter cloacae and one Citrobacter
youngae (Figure 1). In view of b-lactam antibiotics, all 48 isolates
were resistant to ampicillin (AM), the 1st-generation cephalosporin,
cephalothin (CF) and the 3rd-generation cephalosporin, cefpodox-
ime (CPD) (Figure 1). Forty-five (93.8%) isolates were resistant to
the 2nd-generation cephalosporin cefuroxime (CXM); one (2.1%)
isolate to cefoxitin (FOX), 28 (58.3%) isolates to cefotaxime
(CTX), 2 (4.2%) isolates to ceftazidime (CAZ), and 2 (4.2%)
isolates to the 4th-generation cephalosporin cefepime (FEP).
Seventeen strains (35.4%) showed resistance to amoxicillin-
clavulanic acid (AMC). Besides b-lactam resistance, susceptibility
Table 2. Prevalences of animals with ESBL positive isolates.
No. positives No. negatives prevalence 95% confidence interval *
Total 48 523 8.41% 6.32–11.07%
#180 d 39 209 15.73% 11.55–21.00%
181 d–1 y 5 143 3.38% 1.25–8.12%
.1 y 4 171 2.29% 0.73–6.12%
Meat 6 238 2.46% 1.00–5.53%
Dairy 42 285 12.84% 9.51–17.08%
#1 mv./d/100 animals 32 429 6.94% 4.87–9.76%
.1 mv./d/100 animals 16 94 14.55% 8.80–22.85%
*95% confidence interval with Yates’ continuity correction.
doi:10.1371/journal.pone.0071725.t002
Table 3. Farm level risk factors for ESBL shedding.
Risk factor OR 95% Conf. Int. p-value
Prod. type meat 1.00
dairy 5.95 2.48 - 14.30 ,0.001
Movements #1/d/100 anim. 1.00
.1/d/100 anim. 2.37 1.23 - 4.57 0.010
Multivariate logistic regression model.
doi:10.1371/journal.pone.0071725.t003
Table 4. Animal level risk factors for ESBL shedding.
Risk factor OR 95% Conf. Int. p-value
Age #180 d 1.00
181 d–1 y 0.19 0.07 - 0.49 ,0.001
.1 y 0.12 0.04 - 0.36 ,0.001
Logistic regression model.
doi:10.1371/journal.pone.0071725.t004
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to other classes of antibiotics was tested. Hereby, 26 (54.2%)
isolates were resistant to gentamicin (GM), 27 (56.25%) to
streptomycin (S), 21 (43.8%) to nalidixic acid (NA), 20 (41.7%)
to ciprofloxacin (CIP), 36 (75.0%) to tetracycline (TE), 22 (45.8%)
to chloramphenicol (C), and 30 (62.5%) to trimethoprim-
sulfamethoxazole (SXT).
Discussion
In this cross-sectional study, fecal samples of a geographically
representative cattle subpopulation for Switzerland were sampled
at slaughterhouse level to determine the occurrence of ESBL
producing Enterobacteriaceae in the Swiss cattle population younger
than 2 years, and to assess risk factors for shedding such
organisms.
To assess the population prevalence of a pathogen or indicator
organism on a national level, a geographically representative set of
samples needs to be selected. Whilst this is easily achieved for
samples taken on a farm level, where farms to be sampled can be
determined in advance by applying a stratified randomization
scheme, this is typically more difficult for samples taken at the
slaughterhouse. This study demonstrated that the goal of a
geographically representative survey could be achieved with a
carefully planned sampling scheme involving the major cattle
slaughterhouses and additional small abattoirs in areas discon-
nected from the main animal traffic.
To our knowledge, this is the first study on risk factors for
shedding ESBL producing Enterobacteriaceae working with risk
factors derived from animal movement data stored in a national
AMD. Performing risk factor analysis with such data offered
several advantages compared to risk factors derived form surveys,
especially when the samples were collected at the abattoir and not
on the farm. Getting information on animal movements and
mortalities from 571 farms of origin of slaughtered animals via
telephone or email surveys would be very time consuming.
Furthermore, such information would be very imprecise compared
to data from the Swiss AMD whose content is very accurate and
complete.
The overall prevalence of cattle hosting ESBL producing
Enterobacteriaceae found in this study (8.4%; 95% C.I. 6.3–11.1%) is
slightly lower than found in previous, smaller scaled Swiss studies
that reported prevalences of 13.7% [16] and 17.1% [10]. Recent
studies from other countries reported a very low (0.2%) prevalence
in cattle in Korea [17] or even zero prevalence in cattle in Tunisia
[18]. Studies from European countries reported 35.4% (22.2–
50.5% C.I. 95%) in North West England and North Wales [19]
and 4.8% in France [20].
One of the significant risk factors for shedding ESBL producing
Enterobacteriaceae obtained in the final multivariate model was age,
with cattle over 6 months being at a considerably lower risk than
calves (younger than 6 months) This is in accordance with a
previous study of Geser et al. [16] who reported a overall
prevalence of 13.7% in cattle as opposed to a prevalence of
25.3% among calves.
Animals from dairy farms were at a 5.95 times higher risk for
hosting ESBL producing Enterobacteriaceae than animals from beef
or fattening farms. This might be explained by differences between
production types with respect to farming practices and antimicro-
bial compounds applied. In Switzerland, sales of cephalosporins
have increased over the past years, especially the sales of 3rd and
4th generation cephalosporins for intramammary application [21].
Snow et al. [19] reported that in North West England and North
Wales farms that had used 3rd or 4th generation cephalosporins in
livestock during the previous 12 months were nearly 4 times more
likely to host ESBL E. coli. On Swiss dairy farms, calves not in
consideration for breeding are either fattened on their farm of
birth or they are sold to fattening farms at a very young age. Those
fattened on the dairy farms are primarily fed with milk. For
economic reasons, milk that cannot be put on the market because
of elevated cell counts or because of recent antimicrobial
treatments is often fed to calves. Moreover, ESBL hosting
Enterobacteriaceae present on dairy farms might be transmitted to
calves by the fecal-oral route. Calves later to be fattened on
fattening farms leave their dairy farms very few weeks after birth
and are thus at a lower risk for acquiring ESBL producing
Enterobacteriaceae than animals staying on the dairy farms until
slaughter. In comparison to dairy farms, beta-lactam antibiotics,
especially 3rd and 4th generation cephalosporins, do not represent
the predominantly used antimicrobial compounds on beef and
fattening farms. The fact that among 40 animals originating from
the canton of Valais no ESBL producers were found, might also be
explained by the farming type, as meat production is predominant
over milk production in this area.
The number of animal movements per farm per day per 100
animals is a factor related to introduction of new stock, and it was
associated with presence of ESBL Enterobacteriaceae. Animals from
farms with a high number of animal incoming movements in
relation to total farm size were at a 2.37 times higher risk of
hosting ESBL producing Enterobacteriaceae than animals from farms
with a lower level of animal traffic. This is in agreement with Snow
et al. [19] who reported that operating a closed farm policy
reduced the risk of the farm having ESBL E. coli compared to
farms that were open and did not quarantine new cattle.
The confirmation of relatively high rates of ESBL producers in
cattle and the high diversity among the isolates are worrisome and
indicate an established reservoir, especially in dairy farms. A
prudent use of antibiotics, especially of 3rd and 4th generation
cephalosporins, restrictions in feeding milk of treated cows to
calves and management improvements to facilitate the operation
of closed herd policies could represent modes of action towards
reduction of ESBL prevalence in cattle. Experimental studies
would be needed to assess the effectiveness of such measures.
Moreover, this study showed that with a carefully planned
sampling scheme involving the major cattle slaughterhouses and
– in addition – small abattoirs in areas disconnected from the main
animal traffic, geographically representative surveys can be
achieved by taking random samples at the abattoir.
Figure 1. Characteristics and antimicrobial susceptibility profiles of ESBL-producing Enterobacteriaceae isolated from cattle younger
than 2 years. Symbols: black square, positive result or resistant to a specific antimicrobial agent; white square, negative result or susceptible to a
specific antimicrobial. Abbreviations: AM, ampicillin (resistant #13 mm); AMC, amoxicillin-clavulanic acid (resistant #13 mm); CF, cephalothin
(resistant #14 mm); CXM, cefuroxime (resistant #14 mm); FOX, cefoxitin (resistant #14 mm); CPD, cefpodoxime (resistant #17 mm); CTX,
cefotaxime (resistant #14 mm); CAZ, ceftazidime (resistant #14 mm); FEP, cefepime (resistant #14 mm); GM, gentamicin (resistant #10 mm); S,
streptomycin (resistant #11 mm); SXT, trimethoprim-sulfamethoxazole (resistant #10 mm); TE, tetracycline (resistant #11 mm); NA, nalidixic acid
(resistant #13 mm); CIP, ciprofloxacin (resistant #15 mm); C, chloramphenicol (resistant #12 mm). Discrimination between ‘‘susceptible’’ and
‘‘resistant’’ was strictly according to CLSI interpretive criteria. It should be noted, however, that for clinical and therapeutic purposes, ESBL producers
should generally be reported resistant to cephalosporins of all 4 generations and monobactams.
doi:10.1371/journal.pone.0071725.g001
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